Citations (90)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kirsty Wai-Chung Lee & Stephen Lam Chan. (2016) Hepatotoxicity of targeted therapy for cancer. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 789-802.
Read now
Read now
Sarah G Helton & Falk W Lohoff. (2015) Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety Disorders. Pharmacogenomics 16:5, pages 541-553.
Read now
Read now
Frédérique Rodieux, Valérie Piguet, Patricia Berney, Jules Desmeules & Marie Besson. (2015) Pharmacogenetics and Analgesic Effects of Antidepressants in Chronic Pain Management. Personalized Medicine 12:2, pages 163-175.
Read now
Read now
Shitalben R Patel, Taimour Y Langaee, Shan S Wong & Larisa H Cavallari. (2014) Pyrosequencing of the CYP2C9 -1766T>C Polymorphism as a Means of Detecting the CYP2C9*8 Allele. Pharmacogenomics 15:13, pages 1717-1722.
Read now
Read now
Sneha Narasimhan & Falk W Lohoff. (2012) Pharmacogenetics of Antidepressant Drugs: Current Clinical Practice and Future Directions. Pharmacogenomics 13:4, pages 441-464.
Read now
Read now
Stefano Porcelli, Chiara Fabbri, Edoardo Spina, Alessandro Serretti & Diana De Ronchi. (2011) Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1101-1115.
Read now
Read now
Bruce Budowle & Angela van Daal. (2009) Extracting evidence from forensic DNA analyses: future molecular biology directions. BioTechniques 46:5, pages 339-350.
Read now
Read now
Caitlin M. Brown, Brad Reisfeld & Arthur N. Mayeno. (2008) Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates. Drug Metabolism Reviews 40:1, pages 1-100.
Read now
Read now
R. Mikstacka, A. M. Rimando, K. Szalaty, K. Stasik & W. Baer-Dubowska. (2006) Effect of natural analogues of -resveratrol on cytochromes P4501A2 and 2E1 catalytic activities. Xenobiotica 36:4, pages 269-285.
Read now
Read now
T. Niwa, T. Shiraga, S. Yamasaki, K. Ishibashi, Y. Ohno & A. Kagayama. (2003) In vitro activation of 7-benzyloxyresorufin O-debenzylation and nifedipine oxidation in human liver microsomes. Xenobiotica 33:7, pages 717-729.
Read now
Read now
G. J. Pass, S. McLean, I. Stupans & N. Davies. (2001) Microsomal metabolism of the terpene 1,8-cineole in the common brushtail possum (Trichosurus vulpecula), koala (Phascolarctos cinereus), rat and human. Xenobiotica 31:4, pages 205-221.
Read now
Read now
Articles from other publishers (79)
Zhuofan Mou, Jack Spencer, John S. McGrath & Lorna W. Harries. (2023) Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer. Human Genomics 17:1.
Crossref
Crossref
Mert C. Ongun, Nazan Vanli Tonyali, Ozan Kaplan, Ilter Deger, Mustafa Celebier, Nursabah E. Basci Akduman, Dilek Sahin, Aykan Yucel & Melih O. Babaoglu. (2023) Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension. Placenta 137, pages 88-95.
Crossref
Crossref
Abiza Wali, Mashooq Ahmad Dar, Aarif Ali, Iyman Rasool, Lubna Tariq, Azher Arafah, Muneeb U. Rehman, Bashir Ahmad Malla & Adil Farooq Wali. 2023. Pharmacogenomics. Pharmacogenomics
169
194
.
Juan Xia, Nan Hui, Lei Tian, Chengyuan Liang, Jie Zhang, Jifang Liu, Jun Wang, Xiaodong Ren, Xiaolin Xie & Kun Wang. (2022) Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF). Biomedicine & Pharmacotherapy 149, pages 112894.
Crossref
Crossref
Sabine Groeger, Jens Martin Herrmann, Trinad Chakraborty, Eugen Domann, Sabine Ruf & Joerg Meyle. (2022) Porphyromonas gingivalis W83 Membrane Components Induce Distinct Profiles of Metabolic Genes in Oral Squamous Carcinoma Cells. International Journal of Molecular Sciences 23:7, pages 3442.
Crossref
Crossref
Srinivas Banoth, Anjana Devi Tangutur, Archana Anthappagudem, Janaki Ramaiah & Bhima Bhukya. (2020) Cloning and in vivo metabolizing activity study of CYP3A4 on amiodarone drug residues: A possible probiotic and therapeutic option. Biomedicine & Pharmacotherapy 127, pages 110128.
Crossref
Crossref
Li-Xing Tian, Xin Tang, Jun-Yu Zhu, Wei Zhang, Wan-Qi Tang, Jun Yan, Xiang Xu & Hua-Ping Liang. (2020) Cytochrome P450 1A1 enhances Arginase-1 expression, which reduces LPS-induced mouse peritonitis by targeting JAK1/STAT6. Cellular Immunology 349, pages 104047.
Crossref
Crossref
Jennifer Nguyen-Lee, Christine T. Nguyen-Buckley & Ani Bagdasarjana. 2019. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
645
656
.
Xuebin Shi, Xisha Lin, Yingying Zhu, Yafang Ma, Yingqiu Li, Xinglian Xu, Guanghong Zhou & Chunbao Li. (2018) Effects of Dietary Protein from Different Sources on Biotransformation, Antioxidation, and Inflammation in the Rat Liver. Journal of Agricultural and Food Chemistry 66:32, pages 8584-8592.
Crossref
Crossref
K.K. Wolf & M.F. Paine. 2018. Comprehensive Toxicology. Comprehensive Toxicology
74
98
.
Cedric Stephan Graebin. 2018. Sweeteners. Sweeteners
245
261
.
Krithika Lingappan, Suman Maity, Weiwu Jiang, Lihua Wang, Xanthi Couroucli, Alex Veith, Guodong Zhou, Cristian Coarfa & Bhagavatula Moorthy. (2017) Role of Cytochrome P450 (CYP)1A in Hyperoxic Lung Injury: Analysis of the Transcriptome and Proteome. Scientific Reports 7:1.
Crossref
Crossref
M. Martín-De Saro, O. Amancio-Chassin, H. Urueta-Cuéllar, L. González-Huerta & S.A. Cuevas-Covarrubias. (2017) Pharmacokinetics of diclofenac in healthy controls with wild-type phenotype for CYP2C9 shows metabolism variability. Revista Médica del Hospital General de México 80:2, pages 92-96.
Crossref
Crossref
Faezeh Kholousi Adab, Zahra Tahmasebi Fard & Mohammad Esmaeil Akbari. (2017) Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of Iranian Women. Iranian Journal of Cancer Prevention In Press:In Press.
Crossref
Crossref
Alexia Grangeon, Sophie Gravel, Fleur Gaudette, Jacques Turgeon & Veronique Michaud. (2017) Highly sensitive LC–MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human. Journal of Chromatography B 1040, pages 144-158.
Crossref
Crossref
Yee Hock Tan, Shiran Mohd Sidik, Sharifah Noor Akmal Syed Husain, Munn Sann Lye & Pei Pei Chong. (2016) CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study. Asian Pacific Journal of Cancer Prevention 17:1, pages 57-64.
Crossref
Crossref
Cedric Stephan Graebin. 2017. Sweeteners. Sweeteners
1
17
.
Marina Kim, Seymour Katz & Jesse Green. (2015) Drug Management in the Elderly IBD Patient. Current Treatment Options in Gastroenterology 13:1, pages 90-104.
Crossref
Crossref
Krithika Lingappan, Weiwu Jiang, Lihua Wang, Gangduo Wang, Xanthi I. Couroucli, Binoy Shivanna, Stephen E. Welty, Roberto Barrios, M. Firoze Khan, Daniel W. Nebert, L. Jackson Roberts & Bhagavatula Moorthy. (2014) Mice Deficient in the Gene for Cytochrome P450 (CYP)1A1 Are More Susceptible Than Wild-Type to Hyperoxic Lung Injury: Evidence for Protective Role of CYP1A1 Against Oxidative Stress. Toxicological Sciences 141:1, pages 68-77.
Crossref
Crossref
Rashad Kebeish, Ehab Azab, Christoph Peterhaensel & Radwa El-Basheer. (2014) Engineering the metabolism of the phenylurea herbicide chlortoluron in genetically modified Arabidopsis thaliana plants expressing the mammalian cytochrome P450 enzyme CYP1A2. Environmental Science and Pollution Research 21:13, pages 8224-8232.
Crossref
Crossref
Atef G. Hussein, Heba F. Pasha, Hanan M. El-Shahat, Doaa M. Gad & Mostafa M. Toam. (2014) CYP1A1 gene polymorphisms and smoking status as modifier factors for lung cancer risk. Gene 541:1, pages 26-30.
Crossref
Crossref
Anne M. Larson. 2014. Cholestatic Liver Disease. Cholestatic Liver Disease
201
228
.
Anne M. Larson & Matthew Hauswald. 2014. Diseases of the Liver in Children. Diseases of the Liver in Children
23
51
.
A.F. da Silva, D. Sartori, F.C. MacedoJrJr, L.R. Ribeiro, M.H.P. Fungaro & M.S. Mantovani. (2013)
Effects of β-glucan extracted from
Agaricus blazei
on the expression of
ERCC5
,
CASP9
, and
CYP1A1
genes and metabolic profile in HepG2 cells
. Human & Experimental Toxicology 32:6, pages 647-654.
Crossref
Crossref
Nobuyuki Horita, Naoki Miyazawa, Takashi Yoshiyama, Toshinori Tsukahara, Ryohei Takahashi, Jun Tsukiji, Hideaki Kato, Takeshi Kaneko & Yoshiaki Ishigatsubo. (2013) Decreased activities of daily living is a strong risk factor for liver injury by anti‐tuberculosis drugs. Respirology 18:3, pages 474-479.
Crossref
Crossref
Srinivas R. Nalamachu. (2012) Opioid Rotation in Clinical Practice. Advances in Therapy 29:10, pages 849-863.
Crossref
Crossref
Landry K. Kamdem, David A. Flockhart & Zeruesenay Desta. (2011) In Vitro Cytochrome P450-Mediated Metabolism of Exemestane. Drug Metabolism and Disposition 39:1, pages 98-105.
Crossref
Crossref
Kevin C. Brown & Angela D. M. Kashuba. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
11
41
.
Russell E. Lewis & David S. Perlin. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases
317
329
.
P. Bigoniya, A. Shukla & C.S. Singh. (2010) Evaluation of Hepatic Microsomal Enzyme Functional Integrity on Picroliv Pretreatment Against CCl4 Induced Hepatotoxicity. International Journal of Pharmacology 6:3, pages 200-207.
Crossref
Crossref
C.-Y. Lee, T.-Y. Lai, Y.-M. Wu, R.-H. Hu, P.-H. Lee, L.-C. Hsu & M.-K. Tsai. (2010) Gene Expression of P-glycoprotein and Cytochrome P450 3A4 in Peripheral Blood Mononuclear Cells and Correlation With Expression in Liver. Transplantation Proceedings 42:3, pages 834-836.
Crossref
Crossref
Paula Mota, David Silva Moura, Maria Graça Vale, Henriqueta Coimbra, Lina Carvalho & Fernando Regateiro. (2010) CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer. Revista Portuguesa de Pneumologia (English Edition) 16:1, pages 89-98.
Crossref
Crossref
Paula Mota, David Silva Moura, Maria Graça Vale, Henriqueta Coimbra, Lina Carvalho & Fernando Regateiro. (2010) Polimorfismos dos alelos m1 e m2 do gene CYP1A1: Susceptibilidade genética para o cancro do pulmão. Revista Portuguesa de Pneumologia 16:1, pages 89-98.
Crossref
Crossref
K.K. Wolf, M.F. Paine & P.B. Watkins. 2010. Comprehensive Toxicology. Comprehensive Toxicology
53
75
.
David J. Greenblatt & Lisa L. von Moltke. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
625
649
.
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
Ali Acikgöz, Najibulla Karim, Shibashish Giri, Wolfgang Schmidt-Heck & Augustinus Bader. (2009) Two compartment model of diazepam biotransformation in an organotypical culture of primary human hepatocytes. Toxicology and Applied Pharmacology 234:2, pages 179-191.
Crossref
Crossref
José Rueff, João P. Teixeira, Luís Silva Santos & Jorge Francisco Gaspar. (2009) Genetic effects and biotoxicity monitoring of occupational styrene exposure. Clinica Chimica Acta 399:1-2, pages 8-23.
Crossref
Crossref
Russell E. Lewis. 2008.
Aspergillus fumigatus
and Aspergillosis
.
Aspergillus fumigatus
and Aspergillosis
445
456
.
A. Serretti, A. Drago & Michael N Liebman. 2009. Biomarkers for Psychiatric Disorders. Biomarkers for Psychiatric Disorders
315
353
.
Sigal Ben-Zaken Cohen, Peter D. Paré, S. F. Paul Man & Don D. Sin. (2007) The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women. American Journal of Respiratory and Critical Care Medicine 176:2, pages 113-120.
Crossref
Crossref
Beatriz Pérez‐Cadahía, Vanessa Valdiglesias, Eduardo Pásaro, Josefina Méndez & Blanca Laffon. (2007) Genetic Polymorphism in Cytochrome P450 1B1 in a Spanish Population. Basic & Clinical Pharmacology & Toxicology 101:1, pages 70-72.
Crossref
Crossref
Wolfgang Lieb, Juliane Bolbrinker, Angela Döring, Hans-Werner Hense, Jeanette Erdmann, Heribert Schunkert & Reinhold Kreutz. (2006)
No association of the
CYP3A5
*
1
allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy
. Clinical Science 111:6, pages 365-372.
Crossref
Crossref
Upendra A. Argikar, James C. Cloyd, Angela K. Birnbaum, Ilo E. Leppik, Jeannine Conway, Smita Kshirsagar, William S. Oetting, Erin C. Klein & Rory P. Remmel. (2006) Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C19*1/*2 patients. Epilepsy Research 71:1, pages 54-63.
Crossref
Crossref
Alan Brown, Alan Henderson, Charlotte Lane, Mark Lansdell, Graham Maw & Sandy Monaghan. (2006) Small molecule inhibitors of IgE synthesis. Bioorganic & Medicinal Chemistry Letters 16:17, pages 4697-4699.
Crossref
Crossref
Jian Guo, Dejan Nikolic, Lucas R. Chadwick, Guido F. Pauli & Richard B. van Breemen. (2006)
IDENTIFICATION OF HUMAN HEPATIC CYTOCHROME P450 ENZYMES INVOLVED IN THE METABOLISM OF 8-PRENYLNARINGENIN AND ISOXANTHOHUMOL FROM HOPS (
HUMULUS LUPULUS
L.)
. Drug Metabolism and Disposition 34:7, pages 1152-1159.
Crossref
Crossref
Rajanikanth Madabushi, Bruno Frank, Bernd Drewelow, Hartmut Derendorf & Veronika Butterweck. (2006) Hyperforin in St. John’s wort drug interactions. European Journal of Clinical Pharmacology 62:3, pages 225-233.
Crossref
Crossref
Hiroki Yoshitsugu, Masuhiro Nishimura, Chise Tateno, Miho Kataoka, Eiji Takahashi, Yoshinori Soeno, Katsutoshi Yoshizato, Tsuyoshi Yokoi & Shinsaku Naito. (2006) Evaluation of Human CYP1A2 and CYP3A4 mRNA Expression in Hepatocytes from Chimeric Mice with Humanized Liver. Drug Metabolism and Pharmacokinetics 21:6, pages 465-474.
Crossref
Crossref
. 2006. Molekulare Pharmakologie und Toxikologie. Molekulare Pharmakologie und Toxikologie
19
49
.
Reinhold Kreutz, Mike Zuurman, Silke Kain, Juliane Bolbrinker, Paul E. de Jong & Gerjan Navis. (2005) The role of the cytochrome P450 3A5 enzyme for blood pressure regulation in the general Caucasian population. Pharmacogenetics and Genomics 15:12, pages 831-837.
Crossref
Crossref
Wanda Baer-Dubowska & Ewa Ignatowicz. 2005. Carcinogenic and Anticarcinogenic Food Components. Carcinogenic and Anticarcinogenic Food Components.
John Pritchard, Simon Lowes & David Miller. 2005. The Blood-Cerebrospinal Fluid Barrier. The Blood-Cerebrospinal Fluid Barrier
147
173
.
Monette M Cotreau, Lisa L von Moltke & David J Greenblatt. (2005) The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates. Clinical Pharmacokinetics 44:1, pages 33-60.
Crossref
Crossref
Toshifumi ShiragaZenzaburo TozukaRika IshimuraAkio KawamuraAkira Kagayama. (2005) Identification of Cytochrome P450 Enzymes Involved in the Metabolism of FK228, a Potent Histone Deacetylase Inhibitor, in Human Liver Microsomes. Biological and Pharmaceutical Bulletin 28:1, pages 124-129.
Crossref
Crossref
Reinhold Kreutz, Heiko Z??rcher, Silke Kain, Peter Martus, Gerd Offermann & Joachim Beige. (2004) The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients. Pharmacogenetics 14:10, pages 665-671.
Crossref
Crossref
A Serretti & P Artioli. (2004) The pharmacogenomics of selective serotonin reuptake inhibitors. The Pharmacogenomics Journal 4:4, pages 233-244.
Crossref
Crossref
Katalin Monostory, Eszter Hazai & László Vereczkey. (2004) Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chemico-Biological Interactions 147:3, pages 331-340.
Crossref
Crossref
Lis Andersen TorpetCamilla KragelundJesper ReibelBirgitte Nauntofte. (2016)
O
ral
A
dverse
D
rug
R
eactions to
C
ardiovascular
D
rugs
. Critical Reviews in Oral Biology & Medicine 15:1, pages 28-46.
Crossref
Crossref
Blanca Laffon, Beatriz Pérez-Cadahı́a, Eduardo Pásaro & Josefina Méndez. (2003) Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes. Toxicology 186:1-2, pages 131-141.
Crossref
Crossref
Meera Vaswani, Farzana Kadar Linda & Subramanyam Ramesh. (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27:1, pages 85-102.
Crossref
Crossref
Lisa L. von Moltke, James L. Weemhoff, Michael D. Perloff, Leah M. Hesse, Jerold S. Harmatz, Barbara F. Roth‐Schechter & David J. Greenblatt. (2002) Effect of zolpidem on human Cytochrome P450 activity, and on transport mediated by P‐glycoprotein. Biopharmaceutics & Drug Disposition 23:9, pages 361-367.
Crossref
Crossref
Bernd Meibohm, Ingrid Beierle & Hartmut Derendorf. (2002) How Important Are Gender Differences in Pharmacokinetics?. Clinical Pharmacokinetics 41:5, pages 329-342.
Crossref
Crossref
Kiyoshi Nagata & Yasushi Yamazoe. (2002) Genetic Polymorphism of Human Cytochrome P450 Involved in Drug Metabolism. Drug Metabolism and Pharmacokinetics 17:3, pages 167-189.
Crossref
Crossref
Charlotte Herrlinger & Ulrich Klotz. (2001) Drug metabolism and drug interactions in the elderly. Best Practice & Research Clinical Gastroenterology 15:6, pages 897-918.
Crossref
Crossref
I. Sekine & N. Saijo. (2001) Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Annals of Oncology 12:11, pages 1515-1525.
Crossref
Crossref
Ulrich M. Zanger, Joachim Fischer, Sebastian Raimundo, Thomas Stüven, Bernd O. Evert, Matthias Schwab & Michel Eichelbaum. (2001) Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 11:7, pages 573-585.
Crossref
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
Viola Tamási, Árpád Kiss, Ottó Dobozy, András Falus, László Vereczkey & Katalin Monostory. (2001) The Effect of Dexamethasone on P450 Activities in Regenerating Rat Liver. Biochemical and Biophysical Research Communications 286:2, pages 239-242.
Crossref
Crossref
Pascal Bonnabry, Johann Sievering, Thierry Leemann & Pierre Dayer. (2001) Quantitative Drug Interactions Prediction System (Q-DIPS). Clinical Pharmacokinetics 40:9, pages 631-640.
Crossref
Crossref
Angela D. M. Kashuba & Joseph S. Bertino. 2001. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
13
38
.
Dwight H. Oliver, Richard E. Thompson, Constance A. Griffin & James R. Eshleman. (2000) Use of Single Nucleotide Polymorphisms (SNP) and Real-Time Polymerase Chain Reaction for Bone Marrow Engraftment Analysis. The Journal of Molecular Diagnostics 2:4, pages 202-208.
Crossref
Crossref
Juan A. Carrillo & Julio Benitez. (2000) Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications. Clinical Pharmacokinetics 39:2, pages 127-153.
Crossref
Crossref
Thomas Thum & Jürgen Borlak. (2009) Cytochrome P450 mono‐oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. British Journal of Pharmacology 130:8, pages 1745-1752.
Crossref
Crossref
D.F.V. Lewis,. (2000) Modelling Human Cytochromes P450 for Evaluating Drug Metabolism: An Update. Drug Metabolism and Drug Interactions 16:4, pages 307-324.
Crossref
Crossref
Dongtao N. Li, Albrecht Seidel, Michael P. Pritchard, C. Roland Wolf & Thomas Friedberg. (2000) Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics 10:4, pages 343-353.
Crossref
Crossref
K. Ohyama, M. Nakajima, M. Suzuki, N. Shimada, H. Yamazaki & T. Yokoi. (2001)
Inhibitory effects of amiodarone and its
N
‐deethylated metabolite on human cytochrome P450 activities: Prediction of
in vivo
drug interactions
. British Journal of Clinical Pharmacology 49:3, pages 244-253.
Crossref
Crossref
Thomas Thum & Jürgen Borlak. (2000) Gene expression in distinct regions of the heart. The Lancet 355:9208, pages 979-983.
Crossref
Crossref
Monette M Cotreau, Lisa L von Moltke, Margery C Beinfeld & David J Greenblatt. (2000) Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level. Journal of Pharmacological and Toxicological Methods 43:1, pages 41-54.
Crossref
Crossref
E. Tanaka. (1999) Update: genetic polymorphism of drug metabolizing enzymes in humans. Journal of Clinical Pharmacy and Therapeutics 24:5, pages 323-329.
Crossref
Crossref